Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGCG in Duchenne Muscular Dystrophy
NCT01183767Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Dec 2010
- Primary completion
- Sep 2018
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of epigallocatechin gallate in Duchenne muscular dystrophy (DMD), sponsored by Charité – Universitätsmedizin Berlin. Started Dec 2010; status: completed.
02
Drugs
epigallocatechin gallate
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT01183767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01183767.